When insurers stopped receiving cost-sharing reduction payments from the government last year, many significantly upped premiums for certain health plans. Here’s more on why they did it, what they did, and six things healthcare executives should know.
If you’re not asking the right questions, your healthcare organization could be missing out. Here are five questions every healthcare organization should be asking.
A national payer study from Change Healthcare has 10 need-to-know takeaways about value-based innovation.
A new study investigates whether PET scans can help guide treatment in patients with aggressive non-Hodgkin lymphomas.
As a healthcare executive you may not conduct research or administer medications, but you can still play an important role in helping improve treatment for lymphoma as well as other blood cancers. Here are five areas in which you can make an impact.
A lymphoma expert from the Allegheny Health Network Cancer Institute reveals the status of current and pipeline lymphoma treatments and the three new treatments healthcare executives need to keep on their radar.
Recommendations focus on ways to prevent opioid misuse and reduce risk of addiction.
We asked several healthcare executives what they are hearing their colleagues talk about the most. Here’s what they said.
A first-of-its kind study examined the association between using medication to treat OUD and mortality in patients who had a nonfatal opioid overdose.
From the frontlines of healthcare, Sarah Krevans, MBA, MPH, Sutter Health, offers AHIP attendees her ideas on healthcare transformation, future outlook, and consumer empowerment.